Results from Phase 3 study evaluating masitinib in prostate cancer
26/05/2021 – AB Science communicated the results from Phase 3 study evaluating masitinib in prostate cancer during the webcast that was held on May 25, 2021
Masitinib in Prostate Cancer Webcast Presentation
25/05/2021 – Presentation of the webcast held on May 25, 2021 on masitinib in prostate Cancer Download PDF
Live webcast on Tuesday May 25, 2021 on masitinib’s results in prostate cancer
21/05/2021 – AB Science will host a live webcast on May 25, 2021 to discuss recently reported results from the Phase 2B/3 masitinib trial in prostate cancer
Results from masitinib study AB12005 in pancreatic cancer selected for presentation at the ASCO Annual Meeting
20/05/2021 – AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting